Symptoms from mild exposure include dizziness, headache, euphoria, confusion, and nausea.
This means that under mild exposure to organic plasma, the enzyme does not become seriously dysfunctional.
This causes tumor cell death due to necrosis, incase of high dose of temperature time [8, 9, 10] or apoptosis due to mild exposure and cell sensitization to chemotherapy and radiotherapy incase sublethal dose of temperature time [11, 12].
Therefore, symptoms of mild exposure are anticipated to resemble T-cell mediated recall responses, similar T-cell mediatedin test.
Intriguingly, there exists a protective phenomenon, termed hypoxic preconditioning (hPC), that occurs when brief or mild exposure to hypoxia protects against a subsequent more severe hypoxia exposure.
This therapy is focused on controlling pain and other symptoms, using mild exposure, and increasing the capacity step by step in a pain-contingent manner.
Absence of oxygen indicated that the Fe NPs had not undergone oxidation even though mild exposure to air during the synthesis process.
The mean trough concentration ratio of Day 85 (14 days after the last dose) to Day 15 (14 days after the first dose) was 1.79, indicating a mild exposure accumulation.
12 The children with no and mild ETS exposure had similar symptom scores but compared with those with heavy ETS exposure had lower scores (2.3 for no and mild exposure combined vs 2.8 p=0.0048) and were at reduced risk for requiring treatment with long-acting β agonist (24% vs 43% p=0.035) and leukotriene receptor antagonist (74% vs 95% p=0.0002) compared with those with high exposure.
This latter phenomenon is also known as hormesis, where a mild exposure to a stressor induces beneficial effects but is toxic at higher exposure levels (Morse 1998; Costantini et al. 2010).
